Abbott: Q3 sales up 14.5% and plan to separate the Nutrition business
FROM THE WIRE · FINANCE.YAHOO.COM
Abbott ABT delivered a stronger top- and bottom-line performance in the third quarter of 2026. Sales increased 14.5% year over year to $13.01 billion and surpassed the Zacks Consensus Estimate by 0.3%. Adjusted earnings per share (EPS) of $1.42 rose 9.2% from the prior-year…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralMixed results, with sales above and EPS below estimates, plus a planned Nutrition spin-off.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Abbott sales rose 14.5% to 13.01 billion dollars in the third quarter of 2026.
- 02Adjusted EPS of 1.42 dollars fell 0.7% short of consensus.
- 03Abbott plans to separate its Nutrition business into an independent listed company.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets